Page last updated: 2024-09-05

adenosine 2',5'-diphosphate and thromboxane a2

adenosine 2',5'-diphosphate has been researched along with thromboxane a2 in 1 studies

Compound Research Comparison

Studies
(adenosine 2',5'-diphosphate)
Trials
(adenosine 2',5'-diphosphate)
Recent Studies (post-2010)
(adenosine 2',5'-diphosphate)
Studies
(thromboxane a2)
Trials
(thromboxane a2)
Recent Studies (post-2010) (thromboxane a2)
29025,617224429

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dangelmaier, C; Daniel, JL; Jin, J; Kunapuli, SP; Smith, JB1

Other Studies

1 other study(ies) available for adenosine 2',5'-diphosphate and thromboxane a2

ArticleYear
The P2Y1 receptor mediates ADP-induced p38 kinase-activating factor generation in human platelets.
    European journal of biochemistry, 2000, Volume: 267, Issue:8

    Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adenosine Diphosphate; Aspirin; Blood Platelets; Enzyme Activation; Humans; Mitogen-Activated Protein Kinases; p38 Mitogen-Activated Protein Kinases; Platelet Activation; Purinergic P2 Receptor Agonists; Receptors, Purinergic P2Y1; Signal Transduction; Thromboxane A2; Vasoconstrictor Agents

2000